All Search Results
News Releases
Sep 03, 2025, 16:09 ET PLPC-DB™: Non-Cellular Oncology Immunotherapy with STIP-NAM Traceability, Entering a Global Acquisition Window.
for immediate acquisition, subject to due diligence and binding agreements. About OGRD AllianceOGRD Alliance is a global biotechnology group focused on advancing next-generation immunology platforms. With over a decade of research and a strong international regulatory framework,
More news about: OGRD Alliance
Sep 03, 2025, 14:00 ET BioFactura Launches Capitol Biologics - New CDMO Division to Accelerate Biologics Development from Concept to Clinic
Organization (CDMO) division dedicated to supporting the process development, early‑phase clinical manufacturing, and analytical needs of emerging biotechnology companies and U.S. government agencies. Strategically located in the BioHealth Capital Region, Capitol Biologics combines technical excellence,
More news about: BioFactura
Sep 03, 2025, 13:38 ET Seven Rubin and Rudman Partners Named to 2025 Lawdragon 500 Leading Global Real Estate Lawyers
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Sep 03, 2025, 11:43 ET Liebherr unveils New High-Performance refrigerators and freezers for use in research applications
The new series is specifically designed to meet the rigorous demands of biotechnology and pharmaceutical research environments. With a seamless chrome-nickel steel interior, these refrigerators and freezers offer exceptional durability,
More news about: Liebherr Appliances USA
Sep 03, 2025, 10:30 ET GMP Cell Therapy Consumables Market to Reach USD 114.4 Million by 2035, with CAGR 28.9% Driven by Advanced Cell Therapy and Biopharmaceutical Innovation | Vantage Market Research
medicine initiatives. Brazil is a key growth driver with expanding biopharma infrastructure. Increasing investment in biotechnology, medical research, and hospital-based cell therapy programs is strengthening opportunities for GMP consumables in the region. What Role
More news about: Vantage Market Research
Organizations
Resources
Case Studies
PhRMA Increases Blog Readership & Reaches Broader Audiences with Content Syndication
PhRMA, the Pharmaceutical Research and Manufacturers of America, represents leading innovative biopharmaceutical research and biotechnology companies. PhRMA is devoted to advancing public policies in the U.S. and around the world to support innovative medical research, help patients
News Trends
The Tripledemic, Disease Awareness and More Health News Trends
dinner. Luckily, she made a full recovery! Big news in healthcare acquisitions came in December when the biotechnology company Amgen